InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the detailed record of transactions filed by McKenna Mark C., 首席执行官. Insider active across 5 companies, notably Prometheus Biosciences, Inc.. In total, 14 filings have been logged. Split: 1 buy · 0 sell. Total volume traded: €350k. Activity tracked since 1 December 2021. The latest transaction was disclosed on 12 December 2024 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 条申报中的 14 条
McKenna Mark C. is Directeur Général and has reported 13 filings in total. Across the 13 sampled filings, the activity is mainly an option exercise, with purchases totaling EUR 349915, between 2021-12-03 and 2026-07-22, notably at Apogee Therapeutics, Inc. and Prometheus Biosciences, Inc.